Eka Consolidates Leadership in Impact Venture Capital with New $107 Million Fund

Eka, a UK-based venture capital firm, has announced the final close of its second fund, reaching a total of $107 million (approximately £80 million). This milestone positions Eka as the largest early-stage impact venture capital firm in the UK, with a focus on investments in the health, wellbeing, and sustainability sectors. The announcement marks a significant moment for the firm, which since 2018 has been committed to demonstrating how social impact and financial returns can be not only compatible but also mutually reinforcing.

The closing of Fund II brings Eka's total assets under management to $200 million, reflecting a consistent and targeted investment strategy. The firm has expressed gratitude to its supporters and outlined the vision that will guide its next phase of development. This approach aligns with a growing awareness in the technological and financial landscape, where innovation is increasingly valued also based on its ability to generate concrete benefits for society, an aspect that resonates with discussions on responsibility and ethics in the use of advanced technologies such as LLMs.

Eka's Vision: Redefining the Impact-Returns Equation

Since its founding in 2018, Eka has challenged the prevailing view that social impact and economic returns were in tension. Eka's thesis argues that the most compelling commercial opportunities of the coming decade will emerge from companies capable of reshaping society's fundamental systems, including how people eat, maintain wellbeing, move, consume, and power their homes. This perspective is supported by three key structural shifts that guide Eka's investment strategy.

The first is the transition from reactive to preventative healthcare. In 2023, the UK allocated 10.9% of its GDP to health, with total healthcare expenditure estimated at approximately £317 billion for 2024. However, only 5.2% of government healthcare spending is allocated to prevention. Eka identifies significant opportunities in companies focused on early detection, behavioral change, improved access, and digitally delivered care. In this context, the application of advanced data analysis techniques and predictive models, often based on AI and machine learning, can play a crucial role in identifying patterns and personalizing interventions, an area where the capabilities of LLMs could find future applications.

The second shift concerns the decarbonization of consumer-driven emissions. While production-side emissions have declined, consumer activity now represents the largest share of UK emissions, accounting for 26.0% of the total in 2024, with transport contributing a further 16.1%. This reframes climate action as increasingly dependent on consumer behavior, from food to travel, home energy, and purchasing decisions, extending into supply chains and broader infrastructure. Here too, AI-based solutions can optimize processes and inform choices. The third pillar is expanding access to the social determinants of health. Eka highlights the role of technology in widening access to essential products and services, such as insurance and housing, for underserved populations. In these areas, commercial and social returns can align closely, where each new customer represents both growth and measurable impact.

Investment Strategy and Fund I Results

Eka's investment strategy has proven effective with Fund I, which ranks in the top 5% for both DPI (Distributions to Paid-In Capital) and TVPI (Total Value to Paid-In Capital) among 2021 vintage funds. This success is attributable to a consistent approach: Eka led or co-led 90% of deals, with an average cheque size of $2 million, focusing on pre-seed and seed-stage companies. The Fund I portfolio includes names like Runna (acquired by Strava), Urban Jungle, Axle, Hived, Foresight Data Machines, Jude, and Flok Health.

A distinctive element of Eka's strategy is its sourcing approach. Since 2021, 47% of Fund I investments have originated from its in-house, AI-driven sourcing platform. This platform is designed to identify founders operating outside traditional venture networks, often with a focus on systemic challenges and category-defining potential. The use of AI for identifying investment opportunities highlights how, even in the venture capital sector, automation and predictive analytics are becoming indispensable tools, allowing for the discovery of talent and projects that might otherwise go unnoticed.

Future Prospects and the Role of AI in Impact Innovation

With Fund II, Eka plans to invest in up to 30 UK-based pre-seed and seed-stage companies. The firm will maintain an average initial investment of approximately $2 million, alongside significant reserves for follow-on funding, and will continue to lead or co-lead the majority of its deals. The core investment focus remains unchanged—spanning health, essential products and services, and sustainable consumption—but Eka notes that the scale of support it can provide to founders will increase.

Eka's Limited Partners include prominent institutions such as the British Business Bank, Better Society Capital, and several foundations. Their shared conviction that commercial and societal returns can compound together is considered central to the growth of impact investing at scale in the UK. In an era where LLM capabilities and AI solutions are becoming increasingly accessible, including through on-premise deployments that ensure greater data control and optimized TCO, startups supported by Eka could leverage these technologies to accelerate their impact. For those evaluating on-premise deployments, AI-RADAR offers analytical frameworks on /llm-onpremise to assess the trade-offs between control, data sovereignty, and operational costs—crucial aspects for companies aiming to innovate in sensitive sectors like health or social services.